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The  aim  of  the  present  study  was to isolate  hepatoprotective  component  from  Urtica  dioica  Linn.  (whole
plant)  against  CCl4-induced  hepatotoxicity  in-vitro  (HepG2  cells)  and  in-vivo  (rats)  model.  Antioxidant
activity  of  hydro  alcoholic  extract  and  its  fractions  petroleum  ether  fraction  (PEF),  ethyl  acetate  fraction
(EAF),  n-butanol  fraction  (NBF)  and  aqueous  fraction  (AF)  were  determined  by  DPPH  and  NO  radicals  scav-
enging  assay.  Fractions  were  subjected  to in-vitro  HepG2  cell  line  study.  Further,  the most  potent  fraction
(EAF)  was  subjected  to  in-vivo  hepatoprotective  potential  against  CCl4 challenged  rats.  The in-vivo  hepato-
protective  active  fraction  was  chromatographed  on silica  column  to  isolate  the bioactive  constituent(s).
Structure  elucidation  was  done  by  using  various  spectrophotometric  techniques  like UV,  IR, 1H  NMR, 13C
NMR and  MS spectroscopy.  Ethyl  acetate  fraction  (EAF)  of  hydro-alcoholic  extract  of U.  dioica  possessed
the  potent  antioxidant  activity  viz. DPPH  (IC50 78.99 ±  0.17  g/ml)  and  NO (IC50101.39  ± 0.30  g/ml).  The
in-vitro  HepG2  cell line study  showed  that  the EAF  prevented  the  cell damage.  The  EAF signiﬁcantly  atten-
uated  the  increased  liver  enzymes  activities  in  serum  and  oxidative  parameters  in  tissue  of  CCl4-induced
rats,  suggesting  hepatoprotective  and  anti-oxidant  action  respectively.  Column  chromatography  of  most
potent antioxidant  fraction  (EAF)  lead to  the  isolation  of  4-hydroxy-3-methoxy  cinnamic  acid  (ferulic
acid)  which  is responsible  for  its hepatoprotective  potential.  Hence,  the  present  study  suggests  that  EAF
of  hydro-alcoholic  extract  has  signiﬁcant  antioxidant  and  hepatoprotective  potential  on  CCl4 induced
hepatotoxicity  in-vitro  and  in-vivo.
©  2015  Published  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND. Introduction
Liver is one of the important organ of our body and plays a
ital function in the maintenance, performance and regulating
omeostasis of our body [45]. Liver disorders have become one of
he serious health problems and a major cause of morbidity and
ortality all over the world. Nearly 20,000 deaths and 250,000
ew cases have been reported every year [42]. The percentage of
iver toxicity due to various exposures is much higher in develop-
ng countries like India (8–30%) compared to advanced countries
Abbreviations: UD, Urtica dioica;  PEF, petroleum ether fraction; EAF, ethyl acetate
raction; NBF, n-butanol fraction; AF, aqueous fraction; SGOT, serum glutamate
xaloacetate transaminase; SGPT, serum glutamate pyruvate transaminase; ALP,
lkaline phosphatase; CCl4, carbon tetrachloride; MDA, malondialdehyde; CAT, cata-
ase; GSH, glutathione; OD, optical density; HepG2, human hepatocellular carcinoma
ells.
∗ Corresponding author. Tel.: +91 9915 939996; Fax: +91 1870 250002.
E-mail address: ankalia 47@rediffmail.com (A.N. Kalia).
ttp://dx.doi.org/10.1016/j.toxrep.2015.07.020
214-7500/© 2015 Published by Elsevier Ireland Ltd. This is an open access article under license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
(2–3%) [51]. Oxidative stress plays a major role in the develop-
ment of liver diseases. The liver injury is initiated by the various
toxic agents produced by chemicals, alcohol, viruses or by their
bio-activation to chemically reactive metabolites. These metabo-
lites can be free radicals, which either elicits an immune response
or directly affects the biochemistry of the cells by interacting with
cellular macromolecules. Even after the advancement in modern
system of medicine, there is absence of a reliable synthetic liver
protective drug. Hence, natural extracts /products from medicinal
plants are considered to be safe and effective for the treatment of
liver disorders [62]. The plants are the rich source of bioactive com-
pounds viz. natural polyphenols and a number of them are being
used in medicine for liver ailments [65]. The phytoconstituents
(polyphenols) are potent antioxidant and proved to be Hepato-
protective and are used in the treatment of chronic liver injuries
[54].
Experimental models of hepatotoxicity can be produced by
alcohol, paracetamol, CCl4 etc.  The CCl4, is the most common hep-
atotoxic agent used for experimental induction of liver ﬁbrosis [8].
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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his model has been used in studies to examine the deposition of
xtracellular matrix in the ﬁbrotic and cirrhotic liver [40]. CCl4 is
etabolized by cytochrome P4502E1 to the trichloromethyl rad-
cal (0CCl3) and peroxy trichloromethyl radical (0OOCCl3). It has
een reported that one of the cause of CCl4-induced liver injury is
ipid peroxidation, which is induced and accelerated by free radical
erivatives of CCl4 [35].
Urtica dioica Linn. (UD) belonging to family Urticaceae is an
nnual and perennial plant which is commonly known as sting-
ng nettle [32]. The vernacular names of this plant are Bichu
utti in Hindi and Punjabi, Vrishchhiyaa-shaaka in Sanskrit and
hisuun in (Kumaon) folk language [28,6]. Traditionally, the
eaves and roots of this plant are used internally as a blood
uriﬁer, emmenagogue, diuretic, nasal and menstrual haemor-
hage, rheumatic pain, colds and cough [48], liver insufﬁciency
63], stomachache [64], eczema, anemia, nephritis, haematuria,
aundice, menorrhagia and diarrhea [28,57,61]. The different
ypes of medicinal important phytoconstituent present in UD
re steroids [5], terpenoids [13], phenylpropanoids, coumarins
4], polysaccharides [59] and lectins [12], ﬂavonol glycosides
kaempherol-3-O-glucoside, and -3-O-rutinoside; quercetin-3-
-glucoside, and -3-O-rutinoside, isorhamnetin-3-O-glucoside,
3-O-rutinoside and -3-O-neohesperidoside) [5]. The plant has
een reported to have immunostimulatory, anticarcinogenic, anti-
nﬂammatory, antioxidant, antiallergenic [15,1], antiandrogenic
41], hepatoprotective [27], hypoglycemic [17], antiviral [2] activ-
ties. Supplementation of UD leaves beverage has been shown
o have a signiﬁcant protective effect against trichloroacetic acid
nduced liver injury [3,26]. However, there is not any report avail-
ble on the bioactivity guided fractionation leading to isolation
f hepatoprotective component. Hence, the present study was
esigned to investigate the hepatoprotective activity of potent
ntioxidant fraction (EAF) of U. dioica Linn. (whole plant) against
Cl4 induced hepatotoxicity in-vitro and in-vivo.
. Materials and methods
.1. Material
1,1-Diphenyl-2-picryl-hydrazyl (DPPH), L-ascorbic acid, sodium
itroprusside, sulphanilamide (Sigma–Aldrich Co., Mumbai). Phos-
horic acid (H3PO4), N-(1-naphthyl) ethylenediamine dihydrochlo-
ide (NEDD) (Rankem Ltd., New Delhi). Fetal bovine serum (FBS),
hosphate buffered saline (PBS) and dulbecco’s modiﬁed eagle
edium (DMEM) were obtained from Himedia Lab Pvt. Ltd., Mum-
ai. 3-(4,5-dimethyl thiazol-2-yl)-5-diphenyl tetrazolium bromide
MTT), carbon tetrachloride (CCl4), silymarin, trichloro acetic acid
TCA), thiobarbituric acid (TBA), ethylenediaminetetraacetic acid
EDTA), were purchased from sigma aldrich, Co., Mumbai. The
iagnostic kits for serum glutamate oxaloacetate transaminase
SGOT), serum glutamate pyruvate transaminase (SGPT), alkaline
hosphatase (ALP), total protein (TP) and total bilirubin (TB) were
urchased from calkine and coral private Ltd. All solvents used were
f analytical grade and purchased from Rankem (Deejay Corpora-
ion, Jalandhar). Thin layer chromatography (TLC) was  performed
sing silica gel 60F254 (E-Merck). Silica gel (60–120 mesh) used for
olumn chromatography was purchased from CDH (Chemical Cor-
oration, Ludhiana). 1H NMR  and 13C NMR  spectras were recorded
n bruker 400 MHz  spectrometer using TMS  (Tetramethylsilane)
s the internal standard and mass spectra were recorded on ESI-
squire 3000 bruker daltonics instrument. The HepG2 cell line was
btained from National Center for Cell Sciences NCCS, Pune (India).orts 2 (2015) 1101–1110
2.2. Plant material
The whole plant of UD was  collected from the local
areas of Ranikhet, Uttarakhand, India (August–September 2013)
and authenticated by Dr. Sunita Garg from NISCAIR, New
Delhi. The voucher specimen (Ref. NISCAIR/RHMD/Consult/2008-
9/1192/224) was  deposited at the Department of Raw Material
Herbarium and Museum (NISCAIR). Plant drug was shade dried
(<40 ◦C), coarsely powdered and stored in air tight container.
2.3. Extraction and fractionation
The coarsely powdered drug (500 g) was extracted by contin-
uous hot extraction process using soxhlet apparatus with 80%
(v/v) alcohol. The hydro-alcoholic extract was ﬁltered and concen-
trated under reduced pressure to obtain a green semi-solid residue.
This hydro-alcoholic extract was  suspended in water (500 ml)  and
sequentially partitioned with different solvents viz., petroleum
ether, ethyl acetate, n-butanol and aqueous in increasing order of
polarity. The fractions obtained were concentrated under reduced
pressure and yield was calculated.
2.4. Phytochemical screening
The UD extract and its fractions (PEF, EAF, NBF and AF) was qual-
itatively tested for the presence of phytochemicals as per described
standard methods [11,21,56].
2.5. In-vitro Free radical scavenging activity
2.5.1. DPPH radical scavenging activity
The antioxidant activity of UD whole plant extract and its frac-
tion were assessed by determining its ability to scavenge free
radicals. 1, 1-Diphenyl-2-picryl-hydrazyl (DPPH) is a stable free
radical [49]. The 0.1 mM solution of DPPH in methanol was pre-
pared. 1 ml  of this solution was  added to 2 ml of test drug solution
at different concentration (50–250 g/ml). The mixture was shaken
vigorously and allowed to stand at room temperature for 30 min.
Then the absorbance was  measured at 517 nm.  Ascorbic acid was
used as standard. The percentage of scavenging activity was deter-
mined using the following formula:
Percentageofinhibition(%) = Acontrol − Asample
Acontrol
× 100 (1)
where, Acontrol − absorbance of DPPH, Asample − absorbance of DPPH
with test sample.
2.5.2. Nitric oxide scavenging activity
Nitric oxide radical scavenging activity was performed accord-
ing to the method of [14]. Nitric oxide radical is generated from
reaction mixture containing sodium nitroprusside (20 mM)  in
phosphate buffered saline (pH 7.4) when incubated at 25 ◦C for
30 min  [37]. The nitric oxide radical thus generated interacts with
oxygen to produce nitrite ion, which is assayed by mixing with
an equal amount of Griess reagent (1% sulfanilamide in 5% phos-
phoric acid and 0.1% naphthylethylenediamine dihydrochloride in
water) [24] and its absorbance was  measured at 570 nm. Decrease
in absorbance in the presence of different concentrations of test
sample (50–250 g/ml) indicated the nitric oxide scavenging activ-
ity. The ascorbic acid was used as standard. The percentage of nitric
oxide scavenging activity was  determined using the Formula (1).2.6. In-vitro CCl4 induced toxicity in HepG2 cell line
The monolayer HepG2 cell culture was trypsinized and cell
count was adjusted to 1.0 × 105 cells/ml using DMEM medium
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ontaining 10% FBS. Cells were maintained in 5% CO2 humidiﬁed
ncubator at 37 ◦C. Subculturing was done by trypsinization (0.25%)
hen they were reached 80% conﬂuency. To investigate the possi-
le toxic effect, the cells were treated with different fractions of UD
t concentration ranging from (10–100 g/ml) for 24 h. Similarly, to
nduce the toxicity, cells were treated with toxicant (medium con-
aining 1% (v/v) CCl4) at a concentration 100 g/ml for 24 h prior
o each experiment. The cells were pre-treated with different frac-
ion of UD for 2 h before the addition of toxicant. After 24 h, cells
iability was determined by MTT  assay.
.6.1. Cell viability study using MTT  assay
MTT  assay was performed as described previously [38,58].
epG2 cells in the exponential phase were seeded onto 96 well
lates (1 × 104 cells/well), allowed to stay (for 24 h), and treated
ith various concentrations of different fractions of UD, and stan-
ard (silymarin). The culture medium was removed and cells were
ashed with PBS. 100 ml  of the MTT  stock (5 mg/ml) was added to
ach well. After 4 h of incubation, solution was removed and 100 l
f DMSO was added. After 10 min, the absorbance (O.D) was read at
40 nm on an ELISA reader (Tecan, Austria). The data was  recorded
sing the software. The percentage viability was calculated as fol-
ows:
cell  viability
= Mean O.D. of treated wells − Mean O.D. of blank wells
Mean O.D. of control wells − Mean O.D. of blank wells
× 100
ontrol well—cells without test drug, treated well—cells with test
rug, blank well—media only.
.7. In-vivo CCl4 induced hepatotoxicity in rats
.7.1. Experimental animals
Young Wistar rats (180–200 g) breed in the Central Animal
ouse, I.S.F. College of Pharmacy, Moga, Punjab, (India) were used
n the study. Animals were acclimatized to laboratory conditions at
oom temperature prior to experimentation and kept under stan-
ard conditions of a 12 h light/dark cycle with food and water
d libitum in polyacrylic cages. All the experiments were carried
ut between 09.00 and 16.00 h. The experimental protocol was
pproved by the Institutional Animal Ethics Committee (IAEC) of
ollege (ISFCP/IAEC/CPCSEA/2013/149) and carried out in accor-
ance with the guidelines of Committee for Control and Supervision
f Experimentation on Animals (CPCSEA), Government of India on
nimal experimentation.
.7.2. Experimental protocol and procedure
Rats were divided into six groups consisting of six animals in
ach group.
Group I received distilled water containing 0.5% sodium car-
oxymethylcellulose (CMC–Na) (1 ml/kg body weight, p.o.) for 7
ays, and olive oil (1 ml/kg body weight, s.c.) on days 2 and 3.
Group II (CCl4) received 0.5% CMC–Na (1 ml/kg body weight,
.o.) for 7 days, and a 1:1 mixture of CCl4 and olive oil (2 ml/kg
ody weight, s.c.) on days 2 and 3.
Group III was treated with the standard drug silymarin
50 mg/kg body weight, p.o.) [53] daily for 7 days and also received
he CCl4–olive oil mixture (1:1, 2 ml/kg body weight, s.c.) on days
 and 3, 30 min  after administration of silymarin.
Groups IV–VI (test group animals) was administered a dose of
0, 40, and 80 mg/kg body weight of EAF (p.o.) for 7 days. Addition-
lly, 30 min  after administration of EAF, they received a dose of the
Cl4–olive oil mixture (1:1, 2 ml/kg, s.c.) on days 2 and 3.orts 2 (2015) 1101–1110 1103
On day 7, animals were anaesthetized by ketamine, blood was
collected by retro-orbital puncture, allowed to clot, and serum was
separated for assessment of enzyme activity. The rats were sacri-
ﬁced by cervical dislocation; the livers were carefully dissected,
rinsed with ice-cold isotonic saline (0.9% sodium chloride) and
weighed. A 10% (w/v) tissue homogenates were prepared in 0.1 M
phosphate buffer (pH 7.4). The homogenates were centrifuged at
10,000 × g for 15 min  and aliquots of the supernatants were sep-
arated and used for tissue biochemical estimation. Some parts of
the liver tissue were immediately transferred into 10% formalin for
histopathological investigation.
2.7.3. Estimation of serum biochemical parameters
Biochemical parameters were assayed according to standard
methods. Activity of the following serum enzymes was  measured:
serum glutamate oxaloacetate transaminase (SGOT), Serum glu-
tamate pyruvate transaminase (SGPT) and alkaline phosphatase
(ALP), using the method of [29]. Total bilirubin (TB) was measured
by the method of [36]. Serum biochemical parameters were esti-
mated using commercial enzymatic biochemical diagnostic kits.
2.7.4. Estimation of Tissue biochemical parameters
2.7.4.1. Measurement of lipid per oxidation. The extent of lipid per
oxidation in the liver was determined quantitatively by performing
the method as described by [43]. The amount of malondialde-
hyde (MDA) was measured by reaction with thiobarbituric acid at
532 nm using Schimadzu spectrophotometer (Japan). The values
were calculated using the molar extinction coefﬁcient of chro-
mophore (1.56 × 105 M−1 cm−1) and expressed as percentage of
control.
2.7.4.2. Estimation of nitrite. The accumulation of nitrite in the
supernatant, an indicator of the production of nitric oxide was
determined by a colorimetric assay with Greiss reagent (0.1% N-(1-
Napththyl) ethylenediamine dihydrochloride, 1% sulphanilamide
and 5% phosphoric acid). Equal volumes of the supernatant and
the Greiss reagent were mixed and the mixture was incubated for
10 min  at room temperature in the dark. The absorbance was mea-
sured at 540 nm using Schimadzu spectrophotometer (Japan). The
concentration of nitrite in the supernatant was determined from
sodium nitrite standard curve and expressed as percentage of con-
trol [19].
2.7.4.3. Estimation of reduced glutathione levels. Reduced glu-
tathione was  estimated according to the method described by
[10]. 1 ml  supernatant was  precipitated with 1 ml  of 4% sulphos-
alicylic acid and cold digested for 1 h at 4 ◦C. The samples were
then centrifuged at 1200 × g for 15 min  at 4 ◦C. To 1 ml  of the
supernatant obtained, 2.7 ml  of phosphate buffer (0.1 mmol/l,
pH 8) and 0.2 ml  of 5,5′dithio-bis (2-nitrobenzoic acid) (DTNB)
was added. The yellow color developed was  measured at 412 nm
using Schimadzu spectrophotometer (Japan). Results were cal-
culated using molar extinction co-efﬁcient of the chromophore
(1.36 × 104 (mol/l)−1 cm−1) and expressed as percentage of control.
2.7.4.4. Catalase estimation. Brieﬂy, the assay mixture consisted of
12.5 mM H2O2 in phosphate buffer (50 mM of pH 7.0) and 0.05 ml
of supernatant from the tissue homogenate (10%) and the change
in absorbance was  recorded at 240 nm.  The results were expressed
as mM of H2O2 decomposed per milligram of protein/min [33].
2.7.4.5. Protein estimation. The protein content was estimated by
Biuret method [18] using bovine serum albumin as a standard.
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Table 1
Physical properties of hydroalcoholic extract of UD and its various fractions.
Extract /fraction Color Consistency % Yield (w/w)
Hydro-alcoholic extract Greenish brown Semi-solid 11.95
PEF  Greenish yellow Solid mass 1.30
EAF Dark green Semi-solid 4.50
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Table 2
Preliminary phytochemical screening of hydroalcoholic extract of UD and its
fractions.
Class of compound Hydro alcoholic extract PEF EAF NBF AF
Carbohydrates + − − − +
Glycosides + − − + +
Proteins + − − − +
Steroids and triterpenoids + + + + −
Phenolic compounds + − + + +
Flavonoids + − + − +
Amino acids + − − − +
Alkaloids − − − − −
3.4.1. Effect of potent antioxidant fraction (EAF) on hepaticNBF Dark brown Semi-solid 2.90
AF  Light brown Semi-solid 3.25
.7.5. Histopathological studies
Liver tissues were ﬁxed in 10% formalin for at least 24 h, embed-
ed in parafﬁn, and cut into 5 m-thick sections using a rotary
icrotome. The sections were stained with Haematoxylin–eosin
ye and observed under a microscope (Olympus, Japan) to observe
istopathological changes in the liver.
.7.6. Statistical analysis
All experiments were done in triplicate and results were
eported as mean ± S.E.M. (n = 6). The data were analyzed by
ne-way ANOVA, and statistically signiﬁcant effects were further
nalyzed by means comparison using Tukey’s multiple comparison
nalysis. The p < 0.05 was considered to be statistically signiﬁcant.
.8. Isolation of compound
On the basis of in vitro (antioxidant, cell line studies) and
n vivo (hepatoprotective studies), potent fraction EAF (5.00 g) was
harged into silica gel (60–120 mesh size) column. The column was
luted in gradient manner by using Hexane; Hexane: DCM, (9:1,
:2, 7:3, 6:4, 5:5, 4:6, 3:7, 2:8, 1:9), DCM; DCM: ethyl acetate (9:1,
:2, 7:3, 6:4, 5:5, 4:6, 3:7, 2:8, 1:9), ethyl acetate; ethyl acetate:
ethanol (9:1, 8:2, 7:3, 6:4, 5:5, 4:6, 3:7, 2:8, 1:9) and methanol.
otal 580 fractions were collected. Eluents were monitored using
LC on different solvent system. The similar fractions were pooled
n to 7 major sub fraction (Fr-A, B, C, D, E, F) all these sub fraction
ere subjected to antioxidant study. The potent fraction was  kept
or crystallization for isolation of pure compounds. Structure elu-
idation of the isolated compound(s) was carried out by melting
oint and spectral techniques; IR, 1H NMR, 13C NMR  and MS.
.9. HPTLC ﬁngerprinting analysis of potent antioxidant fraction
EAF) of UD
EAF was analyzed for the presence of compound by comparing
ith Rf value and spectral comparison with co-chromatographic
tandard compound ferulic acid. Chromatography was  performed
n precoated aluminium silica gel 60F254 (E-Merck) (4 cm × 10 cm)
lates. EAF and standard compound of known concentrations were
pplied to the layers as 6 mm-wide bands positioned 15 mm from
he bottom and 15 mm from side of the plate, using Camag Lino-
at  5 automated TLC applicator with the nitrogen ﬂow providing a
elivery speed of 90 nL/s from the application syringe. These con-
itions were kept constant throughout the analysis of the samples.
ollowing sample application, layers were developed in a Camag
win through glass chamber that had been presaturated with the
obile phase of toluene: ethyl acetate: formic acid (8:2:0.4), the
eveloped plate were dried with a hair dryer and scanned at the
66 nm with Camag U.V. scanner.
. ResultsThe physical properties and percentage (%) yield of hydro alco-
olic extract and its various fractions are mentioned in Table 1.Saponins + − − − +
(+) Present, (−) Absent.
3.1. Phytochemical studies
Preliminary phytochemical screening of hydroalcohalic extract
and its various fractions are shown in Table 2.
3.2. In-vitro free radical scavenging activity
3.2.1. DPPH radical scavenging activity
The antioxidant activity of hydro alcoholic extract and its
fractions was determined by its capacity to scavenge DPPH
radical. The hydro alcoholic extract and its fractions PEF, EAF,
NBF and AF showed DPPH radical scavenging activity with an
IC50 of 140 ± 0.76 g/ml, 215.96 ± 0.06 g/ml, 78.99 ± 0.17 g/ml,
168.24 ± 0.34 g/ml, 302.90 ± 0.14 g/ml respectively. Ascorbic
acid (IC50 26.24 ± 0.19 g/ml) showed an excellent activity. The
EAF has shown signiﬁcant free radical quenching capacity when
compared to hydroalcoholic extract and other fractions.
3.2.2. Nitric oxide scavenging activity
The nitric oxide scavenging activity of hydroalcoholic extract
and its fractions was determined based on the inhibition of
nitric oxide radical generation from sodium nitroprusside in
buffer saline and measured by Griess reagent. The hydro alco-
holic extract and its fractions PEF, EAF, NBF and AF showed NO
radical scavenging activity with an IC50 of 161.29 ± 0.41 g/ml,
172.38 ± 0.63 g/ml, 101.39 ± 0.30 g/ml, 141.23 ± 0.80 g/ml and
202.26 ± 0.67 g/ml respectively. The standard ascorbic acid IC50
was 45.76 ± 0.62 g/ml. The EAF has shown the signiﬁcant NO free
radical scavenging ability in comparison to hydroalcoholic extract
and other fractions.
3.3. In-vitro CCl4 induced toxicity in HepG2 cell line
3.3.1. Cytoprotective effect of UD fractions in HepG2 cells
The exposure of HepG2 cells to various concentrations
(10–100 g/ml) of UD fractions (PEF, EAF, NBF, and AF) alone for
24 h did not alter the viability. However, exposure of cells to 1% (v/v)
CCl4-induced signiﬁcant cell death. The cell viability was almost
half of control after 24 h exposure (40.66 ± 1.85). Following pre-
treatment of cells with various concentrations (10–100 g/ml) of
UD fractions, exposure to 1% (v/v) CCl4 did not drastically affect the
cell viability. The pretreatment with EAF have prevented, the cell
death and percentage cell viability was concentration dependent.
The result of cell viability are depicts in Table 3.
3.4. In-vivo CCl4 induced hepatotoxicity in ratsmarkers
The hepatoprotective effect of EAF was assessed by measur-
ing liver-related biochemical parameters following CCl4 induced
B.C. Joshi et al. / Toxicology Rep
Table  3
Protective effect of various fraction of UD on CCl4 induced toxicity in HepG2 cell
line.
Group no. Experimental groups Cell viability (%)
Control Normal control 100
Toxicant control CCl4 control (1%, v/v) 40.66 ± 1.85
Silymarin treatment
Silymarin (10 g/ml) + CCl4 (1% v/v) 54.36 ± 2.58
Silymarin (25 g/ml) + CCl4 (1% v/v) 68.15 ± 1.80
Silymarin (50 g/ml) + CCl4 (1% v/v) 77.08 ± 1.59
Silymarin (100 g/ml) + CCl4 (1% v/v) 87.94 ± 3.30
UD fractions treatment
PEF (10 g/ml) + CCl4 (1% v/v) 35.36 ± 2.01
PEF (25 g/ml) + CCl4 (1% v/v) 38.45 ± 1.99
PEF (50 g/ml) + CCl4 (1% v/v) 46.39 ± 1.69
PEF (100 g/ml) + CCl4 (1% v/v) 50.20 ± 1.88
EAF (10 g/ml) + CCl4 (1% v/v) 52.17 ± 1.08
EAF (25 g/ml) + CCl4 (1% v/v) 65.71 ± 1.23
EAF (50 g/ml) + CCl4 (1% v/v) 74.38 ± 2.13
EAF (100 g/ml) + CCl4 (1% v/v) 83.23 ± 1.60
NBF (10 g/ml) + CCl4 (1% v/v) 34.24 ± 2.22
NBF (25 g/ml) + CCl4 (1% v/v) 41.70 ± 2.41
NBF (50 g/ml) + CCl4 (1% v/v) 59.32 ± 3.36
NBF (100 g/ml) + CCl4 (1% v/v) 63.35 ± 2.12
AF (10 g/ml) + CCl4 (1% v/v) 37.27 ± 2.27
AF (25 g/ml) + CCl4 (1% v/v) 46.20 ± 2.94
AF (50 g/ml) + CCl4 (1% v/v) 50.47 ± 3.05
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VAF (100 g/ml) + CCl4 (1% v/v) 54.75 ± 3.16
alues were as expressed mean ± S.E.M. of three independent experiments carried
ut in triplicates.
epatotoxicity. The activity of the enzymes SGOT, SGPT, ALP and
B levels were signiﬁcantly increased in the CCl4-control group
ompared to the normal control group (p < 0.05). However, rats
reated with EAF (20, 40 and 80 mg/kg) signiﬁcantly attenuated
he increase activities of liver enzymes (SGOT, SGPT and ALP) and
B levels in dose dependently in the CCl4-treated rats (p < 0.05)
uggesting hepatoprotective potential. Moreover, the adminis-
ration of standard silymarin (50 mg/kg) showed a signiﬁcant
p < 0.05) hepatoprotective potential against CCl4 induced liver
njury (Table 4).
.4.2. Effect of EAF on oxidative stress parameters (lipid
eroxidation, nitrite, Catalase and reduced glutathione) in CCl4
nduced hepatotoxicity in rats
Chronic administration of CCl4 signiﬁcantly caused oxidative
tress (increased MDA  level, nitrite concentration, depleted cata-
ase and reduced glutathione enzyme activity) as compared to
ehicle treated group. The antioxidant fraction (EAF) (20, 40 and
0 mg/kg) treated group of rats signiﬁcantly attenuated oxida-
ive stress (MDA levels, nitrite concentration and restored the
evel of endogenous antioxidant enzyme viz. catalase and reduced
SH) dose dependently as compared to CCl4 treated rats indicat-
able 4
ffect of potent antioxidant fraction (EAF) of UD on biochemical parameters of CCl4 dama
Groups SGOT (U/L) SGP
Normal-control 25.98 ± 3.76 14
CCl4-control 183.60 ± 5.67a 15
Silymarin (50 mg/kg) 48.42 ± 6.04b 36
EAF (20 mg/kg) 138.40 ± 5.79b 11
EAF (40 mg/kg) 75.99 ± 4.02b,c 72
EAF (80 mg/kg) 53.25 ± 5.51b,c,d 44
alues were expressed as mean ± S.E.M.
a p < 0.05 vs. normal control.
b p < 0.05 vs. CCl4 control group.
c p < 0.05 vs. EAF fraction (20 mg/kg).
d p < 0.05 vs. EAF fraction (40 mg/kg).orts 2 (2015) 1101–1110 1105
ing antioxidant effect. Moreover, the administration of standard
silymarin (50 mg/kg) signiﬁcant (p < 0.05) attenuated the oxidative
damage in CCl4 induced liver injury (Fig. 1a–d).
3.4.3. Histopathological studies
The presence of cell injury in livers by CCl4 was revealed by
histopathological examinations. In the photomicrographs of hema-
toxylin eosin stained liver tissues, normal control hepatocytes had
normal architecture (Fig. 2A). Severe hepatocyte necrosis, fatty
degeneration, vacuolation were found in rats 24 h after CCl4 treat-
ment (Fig. 2B). The effects of silymarin (50 mg/kg body weight) on
liver histopathology of CCl4 treated rat are presented in (Fig. 2C).
Pretreatment of EAF of UD at 20, 40 and 80 mg/kg body weight
reduced the severity of hepatocells of CCl4 induced liver injury
(Fig. 2D–F). These results clearly indicate the protection provided
by potent antioxidant EAF of UD.
3.5. Structure elucidation of isolated compound
The sub fraction (Fr-E) isolated from column has shown the sig-
niﬁcant antioxidant potential with (IC50 value 40.21 ± 0.20 g/ml)
as compared to other fraction in DPPH free radical scavenging
assay. The potent sub fraction (Fr-E) subjected to crystallization.
A pure compound obtained as colorless crystal, 18 mg;  Rf 0.39
(toluene: ethyl acetate: formic acid, 6:3.5:0.5); having a melting
point 168 ◦C. Compound gave positive FeCl3 test for phenolics [39].
UV max  (methanol): 318 nm,  The IR (KBr) cm−1 spectrum showed
the absorption band 3436 ( OH str.), 2923 ( CH3 aliphatic str.),
1690 (>C O str.), 1664 (>C C< str.), 1466 (>C C<), 1035 (C O
str.). The molecular formula, C10H10O4 was  determined by Mass
spectrum with [M+H] at m/z 194.0. Further, when compound was
subjected to 1H NMR  (DMSO-d6, 400 MHz) chemical shift, ı in ppm,
coupling constant, 3.86 (3H,s), 6.27(1H,d, J = 16.0 Hz), 6.81(1H,d,
J = 8.0 Hz), 7.0 (IH, dd, J = 2.0 Hz, J = 2.0 Hz.), 7.49 (1H,d, J = 16.0 Hz.),
7.15 (1H,s), 9.32(1H,s), 11.96(1H,s). 13C NMR (DMSO-d6, 100 MHz)
ı: 55.48( OCH3), 110.49(C5 (Ar.), 115.36(C6, C1′ (Ar.), 122.41(C2
(Ar.), 125.68(C1 (Ar.), 144.26(C2′(>C C<), 147.67–148.89(C3, C4
(Ar.), 168.00( COOH). On the basis of spectral analysis the com-
pound was characterized as ferulic acid (Fig. 3).
3.6. HPTLC ﬁngerprinting analysis of potent antioxidant fraction
(EAF) of UDThe optimized high resolution HPTLC proﬁle was achieved in
the mobile phase of toluene: ethyl acetate: formic acid (8:2:0.4) at
wavelength of 366 nm.  The HPTLC analysis conﬁrmed the presence
of ferulic acid (Rf 0.39) (Figs. 4 and 5).
ged livers in rats.
T (U/L) ALP (U/L) TB (mg/dl)
.23 ± 4.42 128.1 ± 7.04 0.25 ± 0.02
9.1 ± 7.07a 275.9 ± 6.79a 1.19 ± 0.04a
.66 ± 3.89b 150.5 ± 6.95b 0.31 ± 0.02b
6.1 ± 6.42b 237.9 ± 7.26b 0.80 ± 0.03b
.60 ± 4.42b,c 191.4 ± 11.67b,c 0.55 ± 0.02b,c
.52 ± 3.93b,c,d 157.0 ± 5.99b,c,d 0.39 ± 0.02b,c,d
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Fig. 1. Effect of antioxidant fraction (EAF) of UD on biochemical alteration in CCl4 treated rats. a. MDA  level b. Nitrite concentration c. Catalase d. Reduced glutathione (GSH).
Results are expressed as mean ± S.D; ap < 0.05 vs. normal control; bp < 0.05 vs. CCl4 control group; cp < 0.05 vs. EAF (20 mg/kg), dp < 0.05 vs. EAF (40 mg/kg).
F ts. Sections are 6 m thick and photomicrographs are taken at 100×. (A) Normal control
g atment group; (E) EAF (40 mg/kg) treatment group; (F) EAF (80 mg/kg) treatment group.
4
b
p
d
r
nig. 2. Effect of EAF on hepatic cells in liver tissue of CCl4 induced liver injury in ra
roup; (B) CCl4 control group; (C) Silymarin standard groups; (D) EAF (20 mg/kg) tre
. Discussion
Oxidative stress is a process where the physiological balance
etween pro-oxidants and antioxidants is disrupted, resulting in
otential damage for the organism [34]. Alteration in oxidative
efence balance is responsible for liver related disorders which
emains one of the serious health problems worldwide [25]. The
atural antioxidants counteract the oxidative stress induced by Fig. 3. Structure of 4-hydroxy-3-methoxy cinnamic acid (ferulic acid).
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epatotoxins [52]. Therefore, the present study was  designed to
nvestigate the hepatoprotective potential of potent antioxidant
raction of U. dioica Linn. (whole plant) against CCl4 induced hepato-
oxicity in-vitro and in-vivo.  Preliminary phytochemical screening
f EAF showed the presence of triterpenoids, ﬂavonoids and phe-
olic compounds. These compounds have been previously reported
o have antioxidant as well as hepatoprotective potential [30,47].
AF of UD showed promising antioxidant activity in DPPH and NO
adical scavenging assay.
Antioxidant activity of UD fraction on DPPH and NO radicals may
e attributed to a direct role in trapping free radicals by donating
ydrogen atom or electron. The antioxidant activity of (EAF) may
e due to the high ﬂavonoids and phenolic contents as phenolic
ompounds received attention for their high antioxidant activity
46].
HepG2 cells are considered as a reasonable model for study-
ng in-vitro xenobiotics metabolism and toxicity to liver, since they
aintain majority of specialized functions like normal human hep-
tocytes [31]. The percent cell viability has been determined using
TT assay. It is helpful to predict the cell damage [26]. The per-
entage cell viability in MTT  assay showed that EAF signiﬁcantly
p < 0.05) prevented the damage that was induced by CCl4 in the
epG2 cells.
As per the in-vitro antioxidant and cell line study, the EAF frac-
ion has shown the promising antioxidant potential and cytotoxic
otential, so it was selected for in-vivo studies. The results demon-
trated that potent antioxidant fraction (EAF) of UD attenuates the
Cl4-induced elevation of serum SGOT, SGPT, ALP and TB levels
nd oxidative damage (attenuated lipid peroxidation, nitrite levels;
estored catalase and GSH levels).
CCl4 is conventionally used to induce liver injury in rats, fol-
owed by testing of plant extract for their liver protecting property.
Cl4 is actively metabolized in the liver tissues to its highly reac-
ive trichloromethyl free radical CCl30. Trichloromethyl free radical
eacts with cellular macromolecular protein and polyunsaturated
atty acids in presence of molecular oxygen to form more toxic
richloromethyl peroxyl radicals along with H2O2, O2, OH that leads
o liver damage [34].
Fig. 4. HPTLC densitometric scanorts 2 (2015) 1101–1110 1107
The liver injury induced by CCl4 elevates the liver marker
enzymes and release them in to the blood [9]. Treatment with
potent antioxidant fraction (EAF) of UD decreased the serum levels
of SGOT and SGPT toward their respective normal value that is an
indication of stabilization of plasma membrane as well as repair
of hepatic tissue damage caused by toxicant. Instead of ALP is a
marker of pathological alteration in biliary ﬂow [44]. CCl4 induced
elevation of ALP is in line with high levels of serum bilirubin. The
depletion of increased ALP activity with simultaneous suppression
of raised bilirubin level indicates the stabilization of biliary dys-
function in rat liver during the hepatic injury. The effective control
of ALP and bilirubin levels in treated groups points toward an early
improvement in the secretary mechanism of hepatocytes.
Increase in MDA  levels, as evident in CCl4 treated experimental
rats, suggests enhanced lipid peroxidation leading to tissue damage
and failure of antioxidant defense mechanisms to prevent forma-
tion of excessive free radicals. The antioxidant system of liver is
also affected through the lipid peroxidative degradation of bio-
membrane, which is the major cause of hepatotoxicity [16].
The EAF has signiﬁcantly reduced the elevated nitrite concen-
tration. The exposure to reactive and nitrogen species RNOS, may
cause the lipid peroxidation in cell membranes, which generates
reactive species that damage the cell proteins and promote their
degradation [7]. Nitrite is a stable metabolite of NO. It can be used
as marker of the overall formation of NO. The increased nitrite level
as a result of increased NOS activity have been observed in liver
homogenate of rats when exposed to CCl4, indicating that animal
suffered from the oxidative and nitrosative stress.
Catalase plays a vital role in protection against the deleteri-
ous effects of hydrogen peroxide and lipid peroxidation in diseases
related to oxidative stress [66,60]. The GSH act as non-enzymatic
antioxidant bio-molecules present in tissue. It is to remove the free
oxygen species, such as H2O2, superoxide anions & alkoxy radicals,
maintenance of membrane protein thiols, and it acts as a substrate
for GPx and glutathione S-transferase (GST) [55]. GSH maintaining
the body’s antioxidant defence mechanism conjugates with free
radicals directly to protect the integrity of cell membranes [22].
Further, EAF signiﬁcantly restored the reduced GSH and CAT
level and thus prevented the lipid peroxidation. The EAF has
 (at 366 nm)  of ferulic acid.
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lso scavenged reactive free radicals that lessen oxidative dam-
ge to the liver tissue and improve the activities of the hepatic
ntioxidant enzymes. The hepatoprotective potential of the EAF
s dose-dependent as the result have shown (80 mg/kg) maximum
eduction in MDA  level, nitrite concentration and resorted the cata-
ase, reduced GSH level (Fig. 1).
Additionally, histological examination of liver sample showed
hronic necrosis in CCl4 treated rat. When severe liver injury
nduced by CCl4 was markedly reduced by the administration of
AF (20, 40, 80 mg/kg) and silymarin (50 mg/kg), as evident by pres-
nce of normal cellular boundaries, lesser fatty changes, absence of
ecrosis, and ballooning degeneration, broad inﬁltration of lym-
hocytes. The in-vitro and in-vivo antioxidant activities of EAF may
e associated with the ﬂavonoids, phenolic, and terpenoidal com-
ounds present in the fraction which has been known for their
ntioxidant and hepatoprotective activities [23].
EAF was subjected to silica gel column, 7 sub fractions (Fr-
, B, C, D, E, F) were obtained. Further Fr-E showed signiﬁcant
ntioxidant potential (IC50 value 40.21 ± 0.20 g/ml) as compared
o other fractions. The potent sub fraction Fr-E was subjected to
rystallization and it gave one pure compound. The melting point
f that compound was found to be 168 ◦C and it gave positive
eCl3 test for phenolics. Structure of isolated compound was eluci-
ated by spectroscopical studies. The IR spectrum data revealed the
bsorption bands characteristics of hydroxyl group (3436 cm−1),
ethyl group (2923 cm−1), alkane group (1664 cm−1), carbonyl
roup (1690 cm−1) and phenolic group (1035 cm−1). The molecu-
ar formula, C10H10O4 of this compound was determined by ESI–MS
pectrum with [M + H] at m/z 194.0. The compound, when subjected
o 1H NMR  exhibited the carboxylic proton at 11.96 whereas the
henolic proton showed broad singlet at 9.32. There is sharp peak
f three proton of methoxy group attached to the aromatic ring.
he vinylic proton showed at 6.27 and 7.49 which are Trans to each
ther having J = 16.0 Hz. The aromatic protons appeared at 6.81 (C-
13) and 7.15 (C-2). In C NMR  spectrum of compound, the aromatic
arbon C1, C2, C3, C4, C5 and C6 appeared at 125.68, 122.41, 147.67,
48.89, 110.49, 110.49 and 115.36 respectively. The vinylic carbon
ppeared at 144.26 whereas the carboxylic carbon showed signal)  of potent antioxidant fraction (EAF).
at 115.36. The carbon of methoxy group attaches at C-3 appeared
at 55.48. From the above spectral data of compound was identiﬁed
as 4-hydroxy-3-methoxy cinnamic acid which was reported as fer-
ulic acid. The ferulic acid reported to have signiﬁcant antioxidant
potential as well as hepatoprotective activity, hence signiﬁcant
hepatoprotective effect of the potent antioxidant fraction (EAF) is
due to ferulic acid.
EAF was standardized by HPTLC analysis using ferulic acid as a
marker. The quantitative HPTLC analysis has shown the presence of
0.13% w/w ferulic acid. Moreover the ferulic acid already reported
to have hepatoprotective potential [50]. This further supports our
ﬁnding that the ferulic acid is responsible for hepatoprotective
potential of UD.
5. Conclusion
The present study scientiﬁcally conﬁrms that potent antioxidant
fraction EAF of UD supports the highest percentage of hepatopro-
tective potential due to its ability to act as free radical scavenger,
as evident by in-vitro and in-vivo antioxidant potential. The results
suggested that the plant exhibited hepatoprotective effect due to
the presence of phenolic compounds such as ferulic acid which act
as antioxidants. Thus the study provides experimental evidences
and clearly justiﬁes the traditional claims and use in the treatment
of liver diseases.
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